On February 16, after living with metastatic breast cancer, Phyllis Torda, 63, vice president of the Quality Solutions Group at the National Committee for Quality Assurance, passed away.
On February 16, after living with metastatic breast cancer for 8 years, Phyllis Torda, 63, vice president of the Quality Solutions Group at the National Committee for Quality Assurance (NCQA), passed away.
In November 2014, she attended and sat on a panel at The American Journal of Managed Care’s Patient-Centered Oncology Care meeting. There, she discussed defining quality in oncology care and shortcomings in current guidelines for measuring quality in cancer care.
“Quality measure construction has to be really precise,” she said in an interview. “You have to say what you can do and what you can’t do. And so in order for the guidelines to be really helpful for quality measure construction, they need to be more precise than they are now.”
While there are efforts in preventive services to better coordinate the work between guideline and measurement developers, no such movement is going on in oncology. However, Ms Torda thought it might come up in the near future.
She also discussed how to get cancer patients more involved in quality measurements at 3 different levels: as an individual patient, through a patient advisory committee offering constructive criticism to practices, and, finally, at the policy or advocacy level.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen